David says ketamine was a ‘lifesaver’ for his depression. So why are many in Australia missing out?
by Natasha May from Science | The Guardian on (#6FV5Z)
A lack of commercial incentives to get the drug approved for treatment-resistant depression means people cannot afford it
- Follow our Australia news live blog for latest updates
- Get our morning and afternoon news emails, free app or daily news podcast
After being abused as a child, David spent decades searching for a treatment for his depression and anxiety. Like many people with treatment-resistant depression, he was cycled by psychiatrists through a variety of drugs and therapies, but David - who asked for only his first name to be used - said he remained debilitated".
Then in October 2021, at age 64, he began a fortnightly ketamine treatment - and it proved to be a lifesaver".
Continue reading...